ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,467Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 2343

$2.06M Total Retail Price of All Prescriptions

Rank: 8 out of 2343

327 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 327 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 26,869 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

87 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 933 878 1 5
METOPROLOL TARTRATE 884 835 2 7
CRESTOR 876 796 3 30
DIOVAN 753 718 4 23
ZOLPIDEM TARTRATE 717 704 5 24
DOXAZOSIN MESYLATE 651 626 6 98
LOVAZA 633 583 7 113
SYNTHROID 604 587 8 40
JANUVIA 589 565 9 50
FUROSEMIDE 540 519 10 6
ISOSORBIDE MONONITRATE ER 501 488 11 32
CLONIDINE HCL 457 450 12 70
NEXIUM 449 420 13 33
OMEPRAZOLE 446 403 14 4
PLAVIX 426 421 15 38
DEXILANT 420 381 16 184
MECLIZINE HCL 414 408 17 103
LEVOTHYROXINE SODIUM 408 407 18 2
SINGULAIR 406 378 19 100
ATORVASTATIN CALCIUM 376 358 20 10
SIMVASTATIN 355 310 21 1
GLIMEPIRIDE 355 319 21 45
ZETIA 317 317 23 52
WARFARIN SODIUM 316 315 24 8
NISOLDIPINE 305 288 10 25 350
ADVAIR DISKUS 296 266 26 34
BENICAR 291 287 27 93
ALENDRONATE SODIUM 279 253 28 28
ATENOLOL 279 270 28 12
HYDROCHLOROTHIAZIDE 275 247 30 11
AZITHROMYCIN 268 242 31 39
NAMENDA 247 247 32 36
LIPITOR 232 229 33 78
POTASSIUM CHLORIDE 228 221 34 18
CLOPIDOGREL 224 216 35 26
LYRICA 217 194 36 135
CREON 216 216 37 197
ZENPEP 213 199 38 353
VENLAFAXINE HCL 210 203 39 252
LIDODERM 209 195 40 130
GABAPENTIN 209 174 40 16
BYSTOLIC 207 201 42 123
MONTELUKAST SODIUM 201 188 43 181
LISINOPRIL 191 182 44 3
ALLOPURINOL 189 175 45 31
TRIAMTERENE-HCTZ 187 179 46 57
DICYCLOMINE HCL 179 166 47 202
FLUTICASONE PROPIONATE 178 159 48 46
GLIPIZIDE XL 172 172 49 84
VOLTAREN 172 164 49 175
GLIPIZIDE 170 170 51 56
METFORMIN HCL 169 148 52 9
CLOBETASOL PROPIONATE 166 160 53 263
RANITIDINE HCL 166 166 53 43
DONEPEZIL HCL 165 165 55 21
ESCITALOPRAM OXALATE 157 149 56 55
PROCTOZONE-HC 151 137 57 208
NITROSTAT 144 143 58 164
FAMOTIDINE 140 134 59 60
TAMSULOSIN HCL 135 119 60 29
DIOVAN HCT 134 130 61 63
HYDRALAZINE HCL 129 119 62 92
LANSOPRAZOLE 127 126 63 162
KETOCONAZOLE 126 126 64 232
CYCLOBENZAPRINE HCL 124 95 R 65 109
LIDOCAINE 119 101 66 258
COUMADIN 118 118 67 216
SPIRIVA 114 100 68 48
NIFEDIPINE ER 112 103 69 89
ULORIC 110 108 70 340
LOSARTAN POTASSIUM 109 95 71 19
SINGLE USE SWAB 108 106 72 241
CIPROFLOXACIN HCL 105 96 73 72
KLOR-CON 10 105 105 73 134
RANEXA 104 100 75 272
AMMONIUM LACTATE 104 104 75 228
PRAVASTATIN SODIUM 104 104 75 15
PROAIR HFA 104 96 75 86
ALCOHOL SWABS 102 100 79 303
VENLAFAXINE HCL ER 99 82 80 87
ACTOS 98 94 81 125
LEXAPRO 94 85 82 178
ALCOHOL PREP PADS 92 92 83 284
NAPROXEN 91 63 84 108
SERTRALINE HCL 89 89 85 20
FINASTERIDE 82 82 86 80
PROMETHAZINE HCL 80 75 R 87 222
CHLORHEXIDINE GLUCONATE 79 79 88 219
SOTALOL 77 77 89 177
NASONEX 74 71 90 209
PANTOPRAZOLE SODIUM 70 70 91 22
CARVEDILOL 67 67 92 27
NITROGLYCERIN PATCH 67 67 92 147
LEVOCETIRIZINE DIHYDROCHLORIDE 67 66 92 223
ISOSORBIDE DINITRATE 66 66 95 354
METOPROLOL SUCCINATE 65 63 96 14
FLECTOR 64 63 97 439
POLYETHYLENE GLYCOL 3350 62 62 98 54
TEKTURNA 61 61 99 326
EXFORGE 61 60 99 163
ENDOCET 60 54 S2 101 97
SOLARAZE 60 60 101 277
LACTULOSE 59 58 103 139
LANTUS 59 59 103 51
PAROXETINE HCL 58 39 105 66
METHYLPREDNISOLONE 56 49 106 122
HYDROCODONE-ACETAMINOPHEN 56 50 S3 106 13
CLONIDINE 56 47 106 307
LOPERAMIDE 55 54 109 238
CITALOPRAM HBR 55 55 109 17
INSULIN SYRINGE 54 54 111 102
HYDROCORTISONE 53 53 112 225
IPRATROPIUM BROMIDE 53 52 112 192
CELEBREX 51 51 114 71
LABETALOL HCL 51 51 114 153
ENABLEX 51 48 114 319
FEXOFENADINE HCL 51 51 114 240
TRAMADOL HCL 50 39 118 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.